Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13073-13079
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13073
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13073
Group A | Group B | Group C | |
CLR resistance | 23 (79.31) | 28 (93.33) | 21 (91.30) |
CLR susceptibility | 308 (91.39) | 285 (90.19) | 168 (90.81) |
LVX resistance | 51 (94.44) | 46 (92.00) | 30 (93.75) |
LVX susceptibility | 281 (90.01) | 267 (90.20) | 159 (90.34) |
-
Citation: Tong YF, Lv J, Ying LY, Xu F, Qin B, Chen MT, Meng F, Tu MY, Yang NM, Li YM, Zhang JZ. Seven-day triple therapy is a better choice for
Helicobacter pylori eradication in regions with low antibiotic resistance. World J Gastroenterol 2015; 21(46): 13073-13079 - URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13073.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13073